Alternatives to Axsome Therapeutics
Axsome Therapeutics is a Biotech tool: biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders. Here are the 59 closest alternatives, compared on pricing, features and what real users say.
The 20 closest Biotech companies to Axsome Therapeutics
Alto Neuroscience5.0 out of 5 (1)Alto Neuroscience is a clinical-stage biopharmaceutical company developing precision psychiatry medicines for mental health conditions.
BiotechMedTechUpdated 29 Sept 2026
NFL BiosciencesNot ratedBiopharmaceutical company developing innovative botanical drugs for addiction treatment.
BiotechnologyPharmaceuticalsUpdated 5 May 2026
BeiGeneNot ratedA global oncology company developing and commercializing innovative cancer treatments.
BiotechMedTechUpdated 1 Jul 2026
AlectorNot ratedBiotechnology company developing immuno-neurology therapies for neurodegenerative diseases.
BiotechMedTechUpdated 1 May 2026
ANI PharmaceuticalsNot ratedDiversified biopharmaceutical company focused on rare diseases, generics, and established brands.
BiotechPharmaceuticalsUpdated 26 Sept 2026
BraeburnNot ratedDevelops long-acting implantable and injectable therapies for opioid addiction and chronic pain.
BiotechHealthTechUpdated 12 Aug 2026
NRG TherapeuticsNot ratedA biotechnology company developing small molecule drugs to treat neurodegenerative diseases by targeting mitochondrial dysfunction.
BiotechMedTechUpdated 24 Jun 2026- MaasbiolabsNot rated
AI-powered platform accelerating biological research and drug discovery.
BiotechDrug DiscoveryUpdated 26 Jul 2026
Amgen3.0 out of 5 (1)A global biotechnology company discovering, developing, manufacturing, and delivering innovative human therapeutics.
BiotechMedTechUpdated 1 May 2026
EyeGate PharmaceuticalsNot ratedClinical-stage specialty pharmaceutical company developing therapeutics and drug delivery systems for ophthalmic diseases.
BiotechMedTechUpdated 6 May 2026
Denali TherapeuticsNot ratedBiopharmaceutical company developing therapies for neurodegenerative diseases, focusing on crossing the blood-brain barrier.
BiotechHealthTechUpdated 13 Sept 2026
Cradle3.0 out of 5 (1)Cradle Bio B.V. is a Dutch, Swiss biotechnology company that develops software using machine learning for protein engineering. It was founded in 2021 and is base
BiotechHealthTechUpdated 12 Apr 2026
Adaptive BiotechnologiesNot ratedLeveraging the adaptive immune system to diagnose and treat disease.
BiotechHealthTechUpdated 1 Jul 2026
BenchSci2.0 out of 5 (2)AI-powered platform for understanding disease biology and accelerating drug discovery.
BiotechDrug DiscoveryUpdated 9 Sept 2026
Manifold BioNot ratedAI-guided drug discovery platform for tissue-targeted medicines.
BiotechDrug DiscoveryUpdated 7 Jul 2026
Cue Biopharma, .Not ratedDeveloping engineered biologics to harness the immune system for disease treatment.
BiotechDrug DiscoveryUpdated 13 Sept 2026
SynthaceNot ratedSynthace provides a no-code cloud platform for life sciences R&D, enabling scientists to automate experimentation and insight sharing.
BiotechMedTechUpdated 23 Aug 2026
Deep GenomicsNot ratedAI-powered biotechnology company developing RNA therapeutics for genetic diseases.
BiotechDrug DiscoveryUpdated 4 Sept 2026- LELexeo Therapeutics3.0 out of 5 (1)
Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.
BiotechMedTechUpdated 1 May 2026
MoleculentNot ratedMapping cell-cell communication at scale in human tissue.
BiotechLife SciencesUpdated 13 Sept 2026
Showing the 20 closest matches. See the rest on the Axsome Therapeutics profile.